Are you scheduled for or planning to have a biopsy done at UNC Health? For this trial, we are looking for people who are 18 years or older who are suspected or diagnosed with Stage IV/metastatic cancer, including: • Lung: Non-small cell lung cancer (NSCLC), • Head and Neck: Squamous Cell Carcinoma (HSNCC), excluding nasopharyngeal and salivary gland cancer; • Kidney: Clear Cell Renal Cell Carcinoma (ccRCC); • Bladder: Urothelial Carcinoma (UC); Skin: Cutaneous Melanoma, excluding Uveal Melanoma.
Have you been diagnosed with triple negative breast cancer and have residual disease after receiving preoperative therapy and surgery?
Are you a young adult cancer survivor who would like to improve your health? Interested in using technology to support a healthy diet, get more physically active, and make healthy lifestyle changes? Researchers at the University of North Carolina at Chapel Hill are looking for volunteers to sign up for a 3-month research program using a Fitbit activity tracker and mobile app to improve your physical activity and dietary habits.
Do you have stage III colon cancer? Have you already completed surgery? If so, you may qualify for a study that uses a blood test called ctDNA to determine your treatment and to monitor for recurrence.
Do you have metastatic renal cell carcinoma? If so, you may be able to take part in a research study collecting information about how your therapy is affecting your quality of life.
Have you been diagnosed with urothelial carcinoma? If so, you may be able to take part in a research study evaluation of an investigational treatment called FX-909 in cancer patients.
Have you been diagnosed with Liver cancer. If so, you may be able to take part in a research study looking to to measure the efficacy and safety of durvalumab IV solution plus bevacizumab IV solution after transarterial radioembolization(Y90 glass microsphere TARE) in participants with unresectable HCC amenable to locoregional therapy
Do you have advanced or metastatic non small cell lung cancer, squamous cell carcinoma of the head and neck, colorectal cancer, or renal cell carcionma? Have you tried previous therapies that did not work? If so, you may be able to take part in this study. Investigational study drug is provided.
Do you have triple negative breast cancer? Have you had surgery following chemotherapy? You may be able to participate in a study to find out if stopping pembrolizumab infusions after surgery is just as effective at reducing your risk of cancer recurrence.
Help shape the future of lupus! Do you want to provide a game-changing contribution to lupus-centered research? Help us make clinical research more efficient and effective. If you have lupus, you can participate by providing samples we can study, such as blood, urine, saliva, and/or stool, to help doctors combat lupus head-on. Compensation provided.